Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam F Cohen

Showing results (41-50 of 146) with videos related to

Pageof 15
Sort By:
Clinical Pharmacokinetics|August 10, 2010
Risk assessment in extrapolation of pharmacokinetics from preclinical data to humansZvi Teitelbaum, Thierry Lave, Jan Freijer, et al.
British Journal of Clinical Pharmacology|November 14, 2013
Urinary kidney biomarkers for early detection of nephrotoxicity in clinical drug developmentLeonie van Meer, Matthijs Moerland, Adam F Cohen, et al.
British Journal of Clinical Pharmacology|March 17, 2012
Concept-based learning of personalized prescribingRobert Rissmann, Eline A Dubois, Kari L Franson, et al.
Basic & Clinical Pharmacology & Toxicology|January 9, 2017
Clinical Pharmacology Research Internships at the Interface between Academia and Industry: Students' Perceptions and Scientific OutputSebastiaan C Goulooze, Kari L Franson, Adam F Cohen, et al.
Nature Biotechnology|December 29, 2019
Integrating scientific considerations into R&D project valuationSaco J de Visser, Adam F Cohen, Marcel J H Kenter
Clinical Medicine (London, England)|October 5, 2016
European drug market entries 2015 with new mechanisms of actionTitus W P van den Heuvel, Adam F Cohen, Robert Rissmann
British Journal of Clinical Pharmacology|May 4, 2018
Futility of current urine salbutamol doping controlJules A A C Heuberger, Sven C van Dijkman, Adam F Cohen
Handbook of Experimental Pharmacology|November 11, 2019
The Future of Clinical Trial Design: The Transition from Hard Endpoints to Value-Based EndpointsMatthijs D Kruizinga, Frederik E Stuurman, Geert J Groeneveld, et al.
Nature Reviews. Drug Discovery|January 9, 2024
Disproportional inflation of clinical trial costs: why we should care, and what we should do about itHemme J Hijma, Ahnjili Zhuparris, Ewoud-Jan van Hoogdalem, et al.
British Journal of Clinical Pharmacology|July 22, 2021
Dealing with doping. A plea for better science, governance and educationJules A A C Heuberger, April Henning, Adam F Cohen, et al.
Pageof 15

Showing results (41-50 of 146) with videos related to

Sort By:
Pageof 15
Clinical Pharmacokinetics|August 10, 2010
Risk assessment in extrapolation of pharmacokinetics from preclinical data to humansZvi Teitelbaum, Thierry Lave, Jan Freijer, et al.
British Journal of Clinical Pharmacology|November 14, 2013
Urinary kidney biomarkers for early detection of nephrotoxicity in clinical drug developmentLeonie van Meer, Matthijs Moerland, Adam F Cohen, et al.
British Journal of Clinical Pharmacology|March 17, 2012
Concept-based learning of personalized prescribingRobert Rissmann, Eline A Dubois, Kari L Franson, et al.
Basic & Clinical Pharmacology & Toxicology|January 9, 2017
Clinical Pharmacology Research Internships at the Interface between Academia and Industry: Students' Perceptions and Scientific OutputSebastiaan C Goulooze, Kari L Franson, Adam F Cohen, et al.
Nature Biotechnology|December 29, 2019
Integrating scientific considerations into R&D project valuationSaco J de Visser, Adam F Cohen, Marcel J H Kenter
Clinical Medicine (London, England)|October 5, 2016
European drug market entries 2015 with new mechanisms of actionTitus W P van den Heuvel, Adam F Cohen, Robert Rissmann
British Journal of Clinical Pharmacology|May 4, 2018
Futility of current urine salbutamol doping controlJules A A C Heuberger, Sven C van Dijkman, Adam F Cohen
Handbook of Experimental Pharmacology|November 11, 2019
The Future of Clinical Trial Design: The Transition from Hard Endpoints to Value-Based EndpointsMatthijs D Kruizinga, Frederik E Stuurman, Geert J Groeneveld, et al.
Nature Reviews. Drug Discovery|January 9, 2024
Disproportional inflation of clinical trial costs: why we should care, and what we should do about itHemme J Hijma, Ahnjili Zhuparris, Ewoud-Jan van Hoogdalem, et al.
British Journal of Clinical Pharmacology|July 22, 2021
Dealing with doping. A plea for better science, governance and educationJules A A C Heuberger, April Henning, Adam F Cohen, et al.
Pageof 15